These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 26293671)
1. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure. Vandewynckel YP; Laukens D; Devisscher L; Paridaens A; Bogaerts E; Verhelst X; Van den Bussche A; Raevens S; Van Steenkiste C; Van Troys M; Ampe C; Descamps B; Vanhove C; Govaere O; Geerts A; Van Vlierberghe H Oncotarget; 2015 Sep; 6(29):28011-25. PubMed ID: 26293671 [TBL] [Abstract][Full Text] [Related]
2. Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis. Paridaens A; Raevens S; Devisscher L; Bogaerts E; Verhelst X; Hoorens A; Van Vlierberghe H; van Grunsven LA; Geerts A; Colle I Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117681 [TBL] [Abstract][Full Text] [Related]
3. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress. Qin Y; Wang Y; Liu O; Jia L; Fang W; Du J; Wei Y Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):337-345. PubMed ID: 27889204 [TBL] [Abstract][Full Text] [Related]
5. Tauroursodeoxycholic acid enhances the pre-implantation embryo development by reducing apoptosis in pigs. Kim JS; Song BS; Lee KS; Kim DH; Kim SU; Choo YK; Chang KT; Koo DB Reprod Domest Anim; 2012 Oct; 47(5):791-8. PubMed ID: 22151574 [TBL] [Abstract][Full Text] [Related]
6. Chemical chaperone, TUDCA unlike PBA, mitigates protein aggregation efficiently and resists ER and non-ER stress induced HepG2 cell death. Uppala JK; Gani AR; Ramaiah KVA Sci Rep; 2017 Jun; 7(1):3831. PubMed ID: 28630443 [TBL] [Abstract][Full Text] [Related]
7. Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet. Cho EJ; Yoon JH; Kwak MS; Jang ES; Lee JH; Yu SJ; Kim YJ; Kim CY; Lee HS Dig Dis Sci; 2014 Jul; 59(7):1461-74. PubMed ID: 24865256 [TBL] [Abstract][Full Text] [Related]
8. Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, trypsin activation, and acinar cell apoptosis while increasing secretion in rat pancreatic acini. Malo A; Krüger B; Seyhun E; Schäfer C; Hoffmann RT; Göke B; Kubisch CH Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G877-86. PubMed ID: 20671193 [TBL] [Abstract][Full Text] [Related]
9. Polyhexamethyleneguanidine Phosphate-Induced Cytotoxicity in Liver Cells Is Alleviated by Tauroursodeoxycholic Acid (TUDCA) via a Reduction in Endoplasmic Reticulum Stress. Kim SH; Kwon D; Lee S; Ki SH; Jeong HG; Hong JT; Lee YH; Jung YS Cells; 2019 Sep; 8(9):. PubMed ID: 31484321 [TBL] [Abstract][Full Text] [Related]
10. The Hsp90 inhibitor SNX-2112 induces apoptosis of human hepatocellular carcinoma cells: the role of ER stress. Wang X; Wang S; Liu Y; Ding W; Zheng K; Xiang Y; Liu K; Wang D; Zeng Y; Xia M; Yang D; Wang Y Biochem Biophys Res Commun; 2014 Mar; 446(1):160-6. PubMed ID: 24582562 [TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid attenuates gentamicin-induced cochlear hair cell death in vitro. Jia Z; He Q; Shan C; Li F Toxicol Lett; 2018 Sep; 294():20-26. PubMed ID: 29751043 [TBL] [Abstract][Full Text] [Related]
12. Tauroursodeoxycholate, a chemical chaperone, prevents palmitate-induced apoptosis in pancreatic β-cells by reducing ER stress. Zhu Q; Zhong JJ; Jin JF; Yin XM; Miao H Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):43-7. PubMed ID: 22972029 [TBL] [Abstract][Full Text] [Related]
13. The role of tauroursodeoxycholic acid on adipogenesis of human adipose-derived stem cells by modulation of ER stress. Cha BH; Kim JS; Ahn JC; Kim HC; Kim BS; Han DK; Park SG; Lee SH Biomaterials; 2014 Mar; 35(9):2851-8. PubMed ID: 24424209 [TBL] [Abstract][Full Text] [Related]
14. The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice. Tanaka Y; Ishitsuka Y; Hayasaka M; Yamada Y; Miyata K; Endo M; Kondo Y; Moriuchi H; Irikura M; Tanaka K; Mizushima T; Oike Y; Irie T Pharmacol Res; 2015 Sep; 99():52-62. PubMed ID: 26005208 [TBL] [Abstract][Full Text] [Related]
15. 6-Shogaol induces apoptosis in human hepatocellular carcinoma cells and exhibits anti-tumor activity in vivo through endoplasmic reticulum stress. Hu R; Zhou P; Peng YB; Xu X; Ma J; Liu Q; Zhang L; Wen XD; Qi LW; Gao N; Li P PLoS One; 2012; 7(6):e39664. PubMed ID: 22768104 [TBL] [Abstract][Full Text] [Related]
16. [Tauroursodeoxycholic acid suppresses endoplasmic reticulum stress in pulmonary tissues of intermittent hypoxia mice]. Shi Z; Xu L; Zhou R Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 40(11):1165-72. PubMed ID: 26643417 [TBL] [Abstract][Full Text] [Related]
17. The nephroprotective effect of tauroursodeoxycholic acid on ischaemia/reperfusion-induced acute kidney injury by inhibiting endoplasmic reticulum stress. Gao X; Fu L; Xiao M; Xu C; Sun L; Zhang T; Zheng F; Mei C Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):14-23. PubMed ID: 22212133 [TBL] [Abstract][Full Text] [Related]
18. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis. Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237 [TBL] [Abstract][Full Text] [Related]
19. [Effect of Tauroursodeoxycholic acid on cytochrome C-mediated apoptosis in HepG2 cells]. Xie Q; Li GM; Zhou XQ; Liao D; Yu H; Guo Q Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):298-301. PubMed ID: 12773247 [TBL] [Abstract][Full Text] [Related]
20. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis. Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]